Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.
B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is characterized by genetic alterations with high heterogeneity. Precise subtypes with distinct genomic and/or gene expression pattern...